Evidence map›Paper›PMID 27550354›Full record

ArticleAntimicrobial agents and chemotherapy2016

Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family.

M Masud Parvez, Nazia Kaisar, Ho Jung Shin, Jin Ah Jung, Jae-Gook Shin

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. How Science Is Driving Regulatory Guidances.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  11. Review
  12. Review
  13. Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Renal Drug Transporters and Drug Interactions.Clinical pharmacokinetics · 2017
    Review
  20. Evaluation ofAntimicrobial agents and chemotherapy · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M Masud ParvezDepartment of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
Nazia KaisarDepartment of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
Ho Jung ShinDepartment of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
Jin Ah JungDepartment of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Jae-Gook ShinDepartment of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea phshinjg@inje.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Twenty-two currently marketed antituberculosis drugs were comprehensively evaluated for their inhibitory effect on organic anionic transporter (OAT)- and organic cation transporter (OCT)-mediated uptake using stably transfected HEK293 cells in vitro We observed moderate to strong inhibitory effects on OAT1- and OAT3-mediated para-aminohippurate (PAH) uptake and OCT1- and OCT2-mediated N-methyl-4-phenylpylidinium acetate (MPP

Indexed as

1-Methyl-4-phenylpyridiniumAminosalicylic AcidAnimalsAntitubercular AgentsCiprofloxacinHEK293 CellsHumansInhibitory Concentration 50Ion TransportKineticsLevofloxacinLinezolidMetforminOctamer Transcription Factor-1Organic Anion Transporters, Sodium-IndependentOrganic Anion Transport Protein 11-Methyl-4-phenylpyridiniumAminosalicylic AcidAntitubercular AgentsCiprofloxacinLevofloxacinLinezolidMetforminOctamer Transcription Factor-1Organic Anion Transporters, Sodium-IndependentOrganic Anion Transport Protein 1organic anion transport protein 3Organic Cation Transporter 2Organic Cation Transport ProteinsPOU2F1 protein, humanPyrazinamideRifabutinRifampinSLC22A2 protein, humanZidovudine

Identifiers

PMID27550354
PMCPMC5075059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.